Bronhopulmonary dysplasia;Bronkopulmonal dysplasi

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 18, 2007, Pages 2374-2377

  Farstad, Teresa ^a   Bratlid, Dag ^b,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LUNG DYSPLASIA; NEWBORN; PREMATURITY; PROGNOSIS; REVIEW;

BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PROGNOSIS;

EID: 35348919457     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bratlid D, Farstad T. Bronkopulmonal dysplasi - en generell oversikt. Tidsskr Nor Lægeforen 1990; 110: 2521-3.
2. Schmidt B, Asztalos EV, Roberts RS et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 2003; 289: 1124-9.
3. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-9.
4. Northway WH, Rosan RC, Porter DY. Pulmonary diseases following respirator therapy of hyalinemembrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 895-8.
5. Crowley P. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995; 173: 322-35.
6. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993; 328: 861-8.
7. Bancalari E. Changes in pathogenesis and prevention of chronic lung disease of prematurity Am J Perinat 2001; 18: 1-9.
8. Aukland SM, Halvorsen T, Fosse KR et al. Highresolution CT of the chest in children and young adults who were born prematurily: findings in a population-based study. AJR Am J Roentgenol 2006; 187: 1012-8.
9. Lal MK, Manktelow BN, Draper ES et al. Chronic lung disease of prematurity and intrauterine growth retardation: a population-based study. Pediatrics 2003; 111: 483-7.
10. Henderson-Smart DJ, Hutchinson JL, Donoghue DA et al. Prenatal predictors of chronic lung disease in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2006; 91: 40-5.
11. Manktelow BN, Draper ES, Annamalai S et al. Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997. Arch Dis Child Fetal Neonatal Ed 2001; 85: 33-5.
12. Shennan AT, Dunn MS, Ohlsson A et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirements in the neonatal period. Pediatrics 1988; 82: 527-32.
13. Shaw NJ, Kotecha S. Management of infants with chronic lung disease of prematurity in the United Kingdom. Early Hum Develop 2005; 81: 165-70.
14. Chess PR, D'Angio CT, Pryhuber GS et al. Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 171-8.
15. Ambalavanan N, Carlo WA. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 192-9.
16. Bell EF, Accaregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001; (3): CD000503.
17. Varsila E, Hallman M, Venge P et al. Closure of patent ductus arteriosus decreases pulmonary myeloperoxidase in premature infants with respiratory distress syndrome. Biol Neonate 1995; 67: 167-71.
18. Schmidt B, Roberts R, Fanaroff A et al. Indometacin prophylaxis, patent ductus arteriosus , and the risk of bronchopulmonary dysplasia: further analyses from the trial of indomethacin prophylaxis in preterms (TIPP). J Pediatr 2006; 148: 730-4.
19. Watterberg KL, Demers LM, Scott SM et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonal dysplasia develops. Pediatrics 1996; 97: 210-5.
20. Abman SH. Pulmonary hypertension in chronic lung disease of infancy: pathogenesis, pathophysiology, and treatment. I: Bland RD, Coalson JJ, red. Chronic lung disease in early infancy. New York: M. Dekker, 1999: 619-68.
21. Bhandari V, Bizzarro MJ, Shetty A et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006; 117: 1901-6.
22. Kazzi SN, Quasney MW. Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia. J Pediatr 2005; 147: 818-22.
23. Derzbach L, Bokodi G, Treszl A et al. Selectin polymorphism and perinatal morbidity in low-birthweight infants. Acta Paediatrica 2006; 95: 1213-7.
24. The STOP-ROP multicenter study group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial. I. Primary outcomes. Pediatrics 2000; 105: 295-310.
25. Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 2002; 87: 15-8.
26. Rajadurai LNM, Tan SV. Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/chronic lung disease. Cochrane Database Syst Rev 2006; 3: CD005093.
27. Hartnoll G, Betremieux P, Modi N. Randomised controlled trial of postnatal sodium supplementation in infants of 25-30 weeks gestational age: effects on cardiopulmonary adaptation. Arch Dis Child Fetal Neonatal Ed 2001; 85: 29-32.
28. Ambavalanam N, Tyson JE, Kennedy KA et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics 2005; 115: e249-54.
29. Bajeva R, Christou H. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 209-18.
30. Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infants: a systemic review of RCTs. BMC Pediatrics 2001; 1: 1, doi: 10.1186/1471-2431-1-1.
31. Jobe AH. Postnatal corticosteroids for preterm infants - do what we say, not what we do. N Engl J Med 2004; 350: 1349-51.
32. Bhandari A, Panitch HB. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 219-26.